BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.
Financial
PaceMate® Acquires Medtronic Paceart Optima™ System, Bringing Complementary Capabilities to Cardiac Data Management
August 27, 2024 08:00 AM Eastern Daylight Time SARASOTA, Fla.–(BUSINESS WIRE)–PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ system, an on-premises cardiac workflow solution from Medtronic (NYSE: MDT.) This strategic move significantly expands PaceMate’s reach globally, adding nearly 1,000 clinic locations worldwide. This […]
Peijia Medical Announces 2024 Interim Results
HONG KONG, Aug. 26, 2024 /PRNewswire/ — Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months ended June 30, 2024 (“the period”) on August…
Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ transplantation. Getinge’s global reach will expand access of Paragonix’s innovative […]
Acarix AB (publ) publishes Interim Report, April – June 2024
NEW YORK, Aug. 22, 2024 /PRNewswire/ — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-breaking gross profit, driven by the success of…
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences:
Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension
FALLS CHURCH, Va.–(BUSINESS WIRE)–Retension Pharmaceuticals, Inc. is pleased to announce the successful closing of its Series A $10.4 million financing round to initiate a well-powered and controlled Phase 2 clinical study in patients with hypertension uncontrolled on two or more antihypertensives. Inhibition of PDE5 is a long-desired mechanism for enhancing NO-based […]
B-Secur and FIRMINIQ Join Forces to Transform Cardiovascular Health Management
PLANO, Texas & BELFAST, Northern Ireland–(BUSINESS WIRE)–B-Secur, a leader in advanced biosensing technology, and FIRMINIQ, a software product development company specializing in connected health, are proud to announce a strategic partnership aimed at transforming cardiovascular health management globally. “Our new alliance with FIRMINIQ represents a significant leap forward in how we […]
Avive Welcomes Katerina Miras as Vice President of Marketing
SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ — Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras…
Medtronic reports first quarter fiscal 2025 financial results
Product innovation driving growth across diversified health tech portfolio, including Automated Insulin Delivery, Transcatheter Aortic Valve Replacement, Pulsed Field Cardiac Ablation, Pain Stimulation, and Deep Brain Stimulation GALWAY, Ireland, Aug. 20, 2024 /PRNewswire/ — Medtronic…
